These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 15256061)
1. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Shukla S; MacLennan GT; Fu P; Patel J; Marengo SR; Resnick MI; Gupta S Neoplasia; 2004; 6(4):390-400. PubMed ID: 15256061 [TBL] [Abstract][Full Text] [Related]
2. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical analysis of nuclear factor, p38, and cyclin D1 proteins in premalignant lesions and carcinomas of the colorectal mucosa]. Lee SD Korean J Gastroenterol; 2008 Dec; 52(6):359-67. PubMed ID: 19096253 [TBL] [Abstract][Full Text] [Related]
4. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Shishodia S; Majumdar S; Banerjee S; Aggarwal BB Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607 [TBL] [Abstract][Full Text] [Related]
5. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Xu C; Shen G; Chen C; Gélinas C; Kong AN Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023 [TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Sweeney C; Li L; Shanmugam R; Bhat-Nakshatri P; Jayaprakasan V; Baldridge LA; Gardner T; Smith M; Nakshatri H; Cheng L Clin Cancer Res; 2004 Aug; 10(16):5501-7. PubMed ID: 15328189 [TBL] [Abstract][Full Text] [Related]
7. Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Lessard L; Bégin LR; Gleave ME; Mes-Masson AM; Saad F Br J Cancer; 2005 Oct; 93(9):1019-23. PubMed ID: 16205698 [TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212 [TBL] [Abstract][Full Text] [Related]
9. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421 [TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Hu J; Colburn NH Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876 [TBL] [Abstract][Full Text] [Related]
12. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Mishra A; Bharti AC; Varghese P; Saluja D; Das BC Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793 [TBL] [Abstract][Full Text] [Related]
13. Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma. Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X J Pathol; 2004 Dec; 204(5):569-77. PubMed ID: 15481028 [TBL] [Abstract][Full Text] [Related]
14. [Expression of NF-kappa B in human bladder cancer and its clinical significance]. Xie DH; Tang XD; Xia SJ; Tan JM; Wang XH; Cai Y Ai Zheng; 2002 Jun; 21(6):663-7. PubMed ID: 12452071 [TBL] [Abstract][Full Text] [Related]
15. Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors. Corbetta S; Vicentini L; Ferrero S; Lania A; Mantovani G; Cordella D; Beck-Peccoz P; Spada A Endocr Relat Cancer; 2005 Dec; 12(4):929-37. PubMed ID: 16322332 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134 [TBL] [Abstract][Full Text] [Related]
17. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Hafeez BB; Siddiqui IA; Asim M; Malik A; Afaq F; Adhami VM; Saleem M; Din M; Mukhtar H Cancer Res; 2008 Oct; 68(20):8564-72. PubMed ID: 18922932 [TBL] [Abstract][Full Text] [Related]
18. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Catz SD; Johnson JL Oncogene; 2001 Nov; 20(50):7342-51. PubMed ID: 11704864 [TBL] [Abstract][Full Text] [Related]
20. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]